Omega-3 fatty acids and multiple sclerosis: Relationship to depression

Journal of Behavioral Medicine

Volumn 31, Issue 2, 2008, Pages 127-135

  Aupperle, Robin L ^a   Denney, Douglas R ^a   Lynch, Sharon G ^b   Carlson, Susan E ^c   Sullivan, Debra K ^c  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Depression; Fatty acids; Multiple sclerosis; Omega 3; Omega 6

Indexed keywords

MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; DEPRESSION; DIETARY INTAKE; DISEASE ASSOCIATION; ERYTHROCYTE MEMBRANE; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; QUESTIONNAIRE; RELAPSE; REMISSION;

ADULT; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 43049141116     PISSN: 01607715     EISSN: 15733521     Source Type: Journal    
DOI: 10.1007/s10865-007-9139-y     Document Type: Article

References (55)

1. Adams, P. B., Lawson, S., Sanigorski, A., & Sinclair, A. J. (1996). Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31(Suppl), 157-161.
2. Astorg, P., Arnault, N., Czernichow, S., Noisette, N., Galan, P., & Hercberg, S. (2004). Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids 39, 527-535.
3. Bas, M., Altan, T., Dincer, D., Aran, E., Gulper Kaya, H., & Yuksek, O. (2005). Determination of dietary habits as a risk factor of cardiovascular heart disease in Turkish adolescents. European Journal of Nutrition 44, 174-182.
4. Besler, H. T., & Comoǧlu, S. (2003). Lipprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutritional Neuroscience 6, 189-196.
5. Boullerne, A., Petty, K. G., & Geffard, M. (1996). Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis. Journal of Neuroimmunology 65, 75-81.
6. Brownbill, R. A., Petrosian, M., & Ilich, J. Z. (2005). Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. Journal of the American College of Nutrition 24, 177-181.
7. Carlson, S. E., Cooke, R. J., Rhodes, P. G., Peeples, J. M., Werkman, S. H., & Tolley, E. A. (1991). Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: Phospholipid fatty acids. Pediatric Research 30, 404-412.
8. Chang, C. H., Nyenhuis, D. L., Cella, D., Luchetta, T., Dineen, K., & Reder, A. T. (2003). Psychometric evaluation of the Chicago Multiscale Depression Inventory in multiple sclerosis patients. Multiple Sclerosis 9, 160-170.
9. Cherayil, G. D. (1984). Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis. Journal of the Neurological Sciences 63, 1-10.
10. Crawford, P. B., Obarzanek, E., Morrison, J., & Sabry, Z. I. (1994). Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9- and 10-year-old girls. Journal of the American Dietetic Association 94, 626-630.
11. Cunnane, S. C, Ho, S., Dore-Duffy, P., Ells, K. R., & Horrobin, D. F. (1989). Essential fatty acid and lipid profiles in plasma and erythroytes in patients with multiple sclerosis. The American Journal of Clinical Nutrition 50, 801-806.
12. Dalton E. J., & Heinrichs, R. W. (2005). Depression in multiple sclerosis: A quantitative review of the evidence. Neuropsychology 19, 152-158.
13. Dodge, J. T., & Phillips, G. B. (1967). Composition of phospholipids and of phospholipids fatty acids and aldehydes in human red cells. Journal of Lipid Research 8, 667-675.
14. Edwards, R., Peet, M., Shay, J., & Horrobin, D. (1998). Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. Journal of Affective Disorders 48, 149-155.
15. Ervin, R. B., Wright, J. D., Wang, C. Y., & Kennedy-Stephenson, J. (2004). Dietary intake of fats and fatty acids for the United States population: 1999-2000. Advance data 8, 1-6.
16. Farinotti, M., Simi, S., Di Pietrantonj, C., McDowell, N., Brait, L., Lupo, D., et al. (2007). Dietary interventions for multiple sclerosis. Cochrane Database of Systematic Reviews 24, CD004192.
17. Fisher, M., Johnson, M. H., Natale, A. M., & Levine, P. H. (1987). Linoleic acid levels in white blood cells, platelets, and serum in multiple sclerosis patients. Acta Neurologica Scandinavica 76, 241-245.
18. Folch, J., Lees, M., & Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipids from animal tissues. The Journal of Biological Chemistry 226, 497-509.
19. Freeman, M. P., Hibbeln, J. R., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., et al. (2006). Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry 67, 1954-1967.
20. Garland, M. R, Hallahan, B., McNamara, M., Carney, P. A., Grimes, H., Hibbeln, J. R., et al. (2007). Lipids and essential fatty acids in patients presenting with self-harm. The British Journal of Psychiatry 190, 112-117.
21. Goulet, J., Nadeau, G., Lapointe, A., Lamarche, B., & Lemieux, S. (2004). Validity and reproducibility of an interview-administered food frequency questionnaire for healthy French-Canadian men and women. Nutrition Journal 3, 13.
22. Hibbeln, J. R. (1999). Long-chain polyunsaturated fatty acids in depression, related conditions. In M. Peet, I. Glen, & D. F. Horrobin (Eds.), Phospholipid spectrum disorder in psychiatry (pp. 195-210). Carnforth: Marius Press.
23. Hibbeln, J. R., & Salem, N. (1995). Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy. The American Journal of Clinical Nutrition 62, 1-9.
24. Holman, R. T., Johnson, S. B., & Kokmen, E. (1989). Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 86, 4720-4724.
25. Horrobin, D. F., & Bennett, C. N. (1999). Depression and bipolar disorder: Relationships to impaired fatty acid and phospholipids metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing, and osteoporosis. Prostaglandins Leukotrienes, and Essential Fatty Acids 60, 217-234.
26. Joffe, R. T., Lippert, G. P., Gray, T. A., Sawa, G., & Horvath, Z. (1987). Mood disorders and multiple sclerosis. Archives of Neurology 44, 376-378.
27. Johansson, L. R., Solvoll, K., Bjorneboe, G. E., & Drevon, C. A. (1998). Intake of very-long-chain n-3 fatty acids related to social status and lifestyle. European Journal of Clinical Nutrition 52, 716-721.
28. Klerman, G. L, & Weisman, N. W. (1989). Increasing rates of depression. JAMA 261, 229-235.
29. Koch, M., Ramsaransing, G. S. M., Fokkena, R., Heersema, D. J., & De Keyser, J. (2006). Erythrocyte membrane fatty acids in benign and progressive forms of multiple sclerosis. Journal of the Neurological Sciences 244, 123-126.
30. Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444-1452.
31. Lührmann, P. M., Herbert, B. M., Gaster, C., & Neuhauser-Berthold, M. (1999). Validation of a self-administered dietary record for use in the elderly. European Journal of Nutrition 38, 235-240.
32. Maes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R., & Meltzer, H. Y. (1996). Fatty acid composition in major depression: Decreased ω3 fractions in cholesteryl esters and increased C20:4ω6/C20: 5ω3 ration in cholesteryl esters and phospholipids. Journal of Affective Disorders 38, 35-46.
33. Maes, M., Christophe, A., Delanghe, J., Altamura, C., Neels, H., & Meltzer, H. Y. (1999). Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholestryl esters of depressed patients. Psychiatry Research 85, 275-291.
34. McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Scerosis. Annals of Neurology 50, 121-127.
35. Morrison, W. R., & Smith, L. M. (1964). Preparation of fatty acid methyl esters and dimethylacetals. Journal of Lipid Research 5, 606-608.
36. Navarro, X., & Segura, R. (1988). Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurologica Scandinavica 78, 152-157.
37. Navarro, X., & Segura, R. (1989). Red blood cell fatty acids in multiple sclerosis. Acta Neurologica Scandinavica 79, 32-37.
38. Neu, I. S. (1983). Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurologica Scandinavica 67, 151-163.
39. Nightingale, S., Woo, E., Smith, A. D., French, J. M., Gale, M. M., Sinclair, H. M., et al. (1990). Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis. Acta Neurologica Scandinavica 82, 43-50.
40. Noonan, C. W., Kathman, S. J., & White, M. C. (2002). Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 58, 136-138.
41. Nordvik, I., Myhr, K. M., Nyland, H., & Bjerve, K. S. (2000). Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurologica Scandinavica 102, 143-149.
42. Nutrition Coordinating Center (2000). NDS-R food and nutrient database, version 31. Minneapolis: University of Minnesota, [CD-ROM].
43. Nyenhuis, D. L., Luchetta, T., Yamamoto, C., Terrien, A., Bernardin, L., Rao, S. M., et al. (1998). The development, standardization, and initial validation of the Chicago Multiscale Depression Inventory. Journal of Personality Assessment 70, 386-401.
44. Okita, M., Yoshida, S., Yamamoto, J., Suzuki, K., Kaneyuki, T., Kubota, M., et al. (1995). n-3 and n-6 fatty acid intake and serum phospholipid fatty acid composition in middle-aged women living in rural and urban areas in Okayama Prefecture. Journal of Nutritional Science and Vitaminology 41, 313-323.
45. Okuda, N., Ueshima, H., Okayama, A., Saitoh, S., Nakagawa, H., Rodriguez, B. L., et al. (2005). Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: The INTERLIPID study. Atherosclerosis 178, 371-379.
46. Parker, G., Gibson, N. A., Brotchie, H., Heruc, G., Rees, A. M., Hadzi-Pavlovic, D. (2006). Omega-3 fatty acids and mood disorders. American Journal of Psychiatry 163, 969-978.
47. Patten, S. B., & Metz, L. M. (1997). Depression in multiple sclerosis. Psychotherapy and Psychosomatics 66, 286-292.
48. Peet, M., Murphy, B., Shay, J., & Horrobin, D. (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biological Psychiatry 43, 315-319.
49. Rosati, G. (2001). The prevalence of multiple sclerosis in the world: An update. Neurological Sciences 22, 117-139.
50. Schwartz, S., & Leweling, H. (2005). Multiple sclerosis and nutrition. Multiple Sclerosis 11, 24-32.
51. Sharrack, B., & Hughes, R. A. (1999). The Guys Neurological Disability Scale (GNDS): A new disability measure for multiple sclerosis. Multiple Sclerosis 5, 223-233.
52. Šidàk, Z. (1967). Rectangular confidence region for the means of multivariate normal distribution. Journal of the American Statistical Association 62, 626-633.
53. Silvers, K. M., & Scott K. M. (2002). Fish consumption and self-reported physical and mental health status. Public Health Nutrition 5, 427-431.
54. Smuts, C., Borod, E., Peeples, J., & Carlson, S. E. (2003). High-DHA eggs: Feasibility as a means to enhance circulating DHA in mother and infant. Lipids 38, 407-414.
55. Swank, R. L., Lerstad, O., Strom, P., & Barker, J. (1952). Multiple sclerosis in rural Norway; its geographic and occupational incidence in relation to nutrition. The New England Journal of Medicine 246, 721-728.